Delpor, Inc.

[Available On-Demand]
Search General Info
Search Education
Search Partnering Companies
Delpor is a clinical stage life sciences company that utilizes innovative technologies to develop once-yearly therapies for chronic conditions.
Delpor's technologies enable the sustained release of drugs through a small subcutaneous implant (lasting for 6-12 months). The implant is placed under the skin during a simple 5-10 minute in office procedure and it delivers therapeutic levels of the drug for 6-12 months.
Our platform works with CNS drugs, and we are pursuing 6-12 month formulations of drugs targeting Mental Disorders, Neuromuscular Diseases, Neurodegenerative Diseases, Addiction, and other conditions. Our products follow the 505b2 regulatory path for a quick approval
Ticker:
Not Provided
Exchange:
Not Provided
Company Type:
Not Provided
Company Website:
Company HQ State:
California
Company HQ Country:
United States
Year Founded:
2009
Main Therapeutic Focus:
Lead Product in Development:
6-12 Month Risperidone Formulation
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
3
Speaker
photo
CEO
Delpor, Inc.